ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2021 at 11:42 AM.

  1. #1 cafead, May 17, 2021 at 11:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,039
    Likes Received:
    3
    via A 14-year-long partnership with Amgen is coming to an end this week, but Cytokinetics is pressing on to file the heart drug the two companies collaborated on to the FDA—in more of a supporting role than originally planned.

    article source
     
    Quote

Reply to Thread